Nonhuman primates are commonly used as experimental animals due to their biological
resemblance to humans. In patients with cardiac disease, the levels of atrial natriuretic
peptide (ANP) and brain natriuretic peptide (BNP) tend to increase in response to cardiac
damage, and they are thus used as indicators for the diagnosis of human heart failure.
However, no reference values for ANP and BNP have been reported for heart disease in
nonhuman primates. In this study, we recorded the age, sex, and body weight of 202
cynomolgus monkeys, and performed evaluations to assess the ANP and BNP levels,
electrocardiography and echocardiography, and accordingly divided the monkeys into two
groups: healthy monkeys and those with spontaneous cardiac disease. Statistical analysis
was performed to determine the relationship of ANP and BNP with the factors of age, sex,
and body weight. No significant relationship was found between the levels of ANP and BNP
and the factors of age, sex, and body weight. However, both the ANP and BNP levels were
significantly different between the healthy monkeys and monkeys with valvular disease.
Similar to humans, the ANP and BNP levels tended to increase with the progression of
cardiac disease in monkeys. Based on these results, we concluded that ANP and BNP are
indicators of cardiac disease in nonhuman primates, and that this nonhuman primate cardiac
disease model is applicable for cardiology research in humans.